Combination bronchodilators and respiratory agents

BRONCHIA/TRACHEA EPITHELIAL CELL BASAL MEDIUM (500 ML)

BRONCHIA/TRACHEA EPITHELIAL CELL GROWTH SUPPLEMENT (5 ML-4 PARTS)

Human Normal Lung GenLysate™

The parent CysLT produced by the LTC4 synthase-catalyzed conjugation of glutathione to LTA4 potent inducer of bronchoconstriction and enhanced vascular permeability that contributes to the pathogenesis of asthma and acute allergic hypersensitivity.

The parent CysLT produced by the LTC4 synthase-catalyzed conjugation of glutathione to LTA4 potent inducer of bronchoconstriction and enhanced vascular permeability that contributes to the pathogenesis of asthma and acute allergic hypersensitivity.

The parent CysLT produced by the LTC4 synthase-catalyzed conjugation of glutathione to LTA4 potent inducer of bronchoconstriction and enhanced vascular permeability that contributes to the pathogenesis of asthma and acute allergic hypersensitivity.

General description The lung epithelium undergoes a complex series of endoderm–mesoderm-mediated signaling events to generate a complex arborized network of conducting airway (bronchi, bronchioles) and gas-exchanging units (alveoli). Lung

Rabbit Normal Lung GenLysate™

Species : Rat Assay Principle : Quantitative Target Name : Pulmonary surfactant-associated protein A Sensitivity : 0.6pg/ml Detection Range : 3pg/ml-200 pg/ml

SDZ-MKS 492 (MKS 492) is a selective inhibitor of cyclic GMP-inhibited phosphodiesterase (type III PDE) . SDZ-MKS 492 inhibits antigen- or platelet activating factor (PAF)-induced bronchoconstriction and allergic reactions in guinea pigs and ratsIn

SDZ-MKS 492 (MKS 492) is a selective inhibitor of cyclic GMP-inhibited phosphodiesterase (type III PDE) . SDZ-MKS 492 inhibits antigen- or platelet activating factor (PAF)-induced bronchoconstriction and allergic reactions in guinea pigs and ratsIn

SDZ-MKS 492 (MKS 492) is a selective inhibitor of cyclic GMP-inhibited phosphodiesterase (type III PDE) . SDZ-MKS 492 inhibits antigen- or platelet activating factor (PAF)-induced bronchoconstriction and allergic reactions in guinea pigs and ratsIn